COPPINI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.960
EU - Europa 7.057
AS - Asia 4.496
SA - Sud America 657
AF - Africa 115
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.833
PL - Polonia 2.151
RU - Federazione Russa 1.971
SG - Singapore 1.256
CN - Cina 1.146
IT - Italia 1.075
HK - Hong Kong 617
BR - Brasile 515
VN - Vietnam 510
IE - Irlanda 414
KR - Corea 334
SE - Svezia 302
DE - Germania 233
FR - Francia 215
FI - Finlandia 165
GB - Regno Unito 151
IN - India 141
JO - Giordania 103
ID - Indonesia 90
CH - Svizzera 89
BD - Bangladesh 68
UA - Ucraina 66
CA - Canada 60
JP - Giappone 60
AU - Australia 59
AR - Argentina 57
TR - Turchia 54
NL - Olanda 50
ES - Italia 40
MX - Messico 40
BE - Belgio 38
ZA - Sudafrica 30
IQ - Iraq 23
EC - Ecuador 21
CI - Costa d'Avorio 19
GR - Grecia 18
VE - Venezuela 16
NG - Nigeria 15
PK - Pakistan 14
CL - Cile 13
AT - Austria 12
MA - Marocco 12
LT - Lituania 11
CO - Colombia 9
KE - Kenya 9
PH - Filippine 9
RO - Romania 9
PY - Paraguay 8
UZ - Uzbekistan 8
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
PE - Perù 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
NP - Nepal 6
SA - Arabia Saudita 6
HU - Ungheria 5
JM - Giamaica 5
KW - Kuwait 5
MY - Malesia 5
AL - Albania 4
BJ - Benin 4
DK - Danimarca 4
GE - Georgia 4
IL - Israele 4
NO - Norvegia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
MK - Macedonia 2
MU - Mauritius 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
Totale 21.326
Salva come PNG Salva come JPEG
Città #
Warsaw 2.141
Santa Clara 1.710
Ashburn 1.189
Singapore 896
Fairfield 742
Hong Kong 538
Dublin 404
Chandler 369
Woodbridge 343
Seoul 330
San Jose 325
Seattle 319
Cambridge 297
Florence 286
Houston 265
Beijing 260
Wilmington 245
Hefei 226
Ann Arbor 217
Ho Chi Minh City 153
Council Bluffs 134
Lawrence 128
Dallas 125
Altamura 124
Buffalo 124
Munich 124
Los Angeles 119
The Dalles 109
Lauterbourg 106
Hanoi 102
Princeton 99
New York 96
Bern 83
Moscow 78
Mumbai 74
Jakarta 68
Boston 65
Helsinki 64
Shanghai 62
Dong Ket 57
San Diego 57
Medford 56
Rome 56
São Paulo 53
Tokyo 53
Melbourne 48
Kent 46
Milan 45
Turku 43
Boardman 42
Clifton 41
Brussels 35
Falls Church 35
Orem 35
Frankfurt am Main 33
Paris 32
London 30
Barcelona 27
Istanbul 26
Chicago 24
Montreal 24
Redondo Beach 24
Norwalk 23
Rio de Janeiro 23
Bologna 22
Phoenix 22
Toronto 22
Lappeenranta 21
Abidjan 19
Guangzhou 19
Da Nang 18
Andover 17
Dearborn 17
Johannesburg 17
Redwood City 17
Scandicci 17
Atlanta 15
Mexico City 15
Abuja 14
Bengaluru 14
Chennai 14
Denver 14
Falkenstein 14
Poplar 14
Amsterdam 13
Haiphong 12
Tianjin 12
Brasília 11
Brooklyn 11
Hillsboro 11
Mudanya 11
Nuremberg 11
Yubileyny 11
Nanjing 10
Naples 10
Poggio A Caiano 10
Washington 10
Biên Hòa 9
Redmond 9
Siena 9
Totale 14.619
Salva come PNG Salva come JPEG
Nome #
Ipertensione arteriosa LINEE GUIDA REGIONE TOSCANA 573
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 468
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 415
Atrial Remodeling in Hypertrophic Cardiomyopathy 392
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 365
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 340
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 320
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 306
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 300
Oleuropein aglycone protects against MAO-A-induced autophagy impairment and cardiomyocyte death through activation of TFEB. 294
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 286
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 275
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 273
Electrical defects of the transverse-axial tubular system in cardiac diseases 272
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 270
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 262
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 260
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 258
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 257
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 234
Design of muscle contraction assist devices by liquid crystalline elastomers 232
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 227
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 226
Action potential propagation in transverse-axial tubular system is impaired in heart failure 223
Arrhythmia susceptibility in a rat model of acute atrial dilation 221
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 220
Real-time optical manipulation of cardiac conduction in intact hearts 217
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 212
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 209
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 204
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 202
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 201
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 197
The transverse-axial tubular system of cardiomyocytes. 196
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 195
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 194
Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications 192
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 192
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 190
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 189
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 189
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 185
Impact of detubulation on force and kinetics of cardiac muscle contraction 184
Whole heart cytoarchitecture at micron-scale resolution 184
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 182
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 182
Functional cardiac imaging by random access microscopy 181
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 181
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial 178
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 176
R4496C RyR2 mutation impairs atrial and ventricular contractility 175
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 173
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 172
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 172
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 171
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 171
Optical clearing in cardiac imaging: A comparative study 171
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 169
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 167
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 166
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 166
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 165
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 163
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 162
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 161
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 160
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 157
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 157
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 157
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 157
Altered calcium regulation in isolated cardiomyocytes from Egr-1 knock-out mice 155
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 152
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 150
Sex-Specific Classification of Drug-Induced Torsade de Pointes Susceptibility Using Cardiac Simulations and Machine Learning 150
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 149
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 149
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 149
Impact of R4496C RyR2 mutation on myocardial contractility 145
BPS2025 - Long-term effect of Mavacamten impact force and sarcomere density in a MYBPC3 iPSC-cardiomyocyte model of hypertrophic cardiomyopathy 143
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 143
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 143
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 142
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 142
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 141
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 141
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 139
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy 138
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 138
Neural Effects on Cardiac Electrophysiology 138
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 Abstracts 135
Clinical research in neonates and infants: Challenges and perspectives 135
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy 135
Targets for therapy in sarcomeric cardiomyopathies. 134
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside 133
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy 128
T-tubule remodeling in human hypertrophic cardiomyopathy 128
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 128
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy 125
Letter to the Editor 125
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 124
Totale 19.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 0 90 93
2021/2022890 41 49 78 41 50 51 51 46 49 65 149 220
2022/20231.973 165 364 102 116 122 306 234 104 268 27 63 102
2023/2024885 37 91 111 37 52 127 51 179 17 54 50 79
2024/20255.732 237 658 376 805 1.465 694 132 385 294 138 242 306
2025/20266.678 715 958 667 819 826 267 765 387 527 482 265 0
Totale 21.559